Abstract:Background Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Intrahepatic metastasis, such as portal vein tumor thrombosis (PVTT), strongly indicates poor prognosis of HCC. But now, there are limited understandings of the molecular features and mechanisms of those metastatic HCCs. Methods To characterize the molecular alterations of the metastatic HCCs, we implemented an integrative analysis of the copy number variations (CNVs), DNA methylations and transcriptomes of matched adjacent normal, primary tumor and PVTT samples from 19 HCC patients. Results CNV analysis identified a frequently amplified focal region chr11q13.3 and a novel deletion peak chr19q13.41 containing three miRNAs. The integrative analysis with RNA-seq data suggests that CNVs and differential promoter methylations regulate distinct oncogenic processes. Then, we used individualized differential analysis to identify the differentially expressed genes between matched primary tumor and PVTT of each patient. Results show that 5 out of 19 studied patients acquire evidential progressive alterations of gene expressions (more than 1000 differentially expressed genes were identified in each patient). While, another subset of eight patients have nearly identical gene expressions between the corresponding matched primary tumor and PVTT. Twenty genes were found to be recurrently and progressively differentially expressed in multiple patients. These genes are mainly associated with focal adhesion, xenobiotics metabolism by cytochrome P450 and amino acid metabolism. For several differentially expressed genes in metabolic pathways, their expressions are significantly associated with overall survivals and vascular invasions of HCC patients. The following transwell assay experiments validate that they can regulate invasive phenotypes of HCC cells. Conclusions The metastatic HCCs with PVTTs have significant molecular alterations comparing with adjacent normal tissues. The recurrent alteration patterns are similar to several previously published general HCC cohorts, but usually with higher severity. By an individualized differential analysis strategy, the progressively differentially expressed genes between the primary tumor and PVTT were identified for each patient. A few patients aquire evidential progressive alterations of gene expressions. And, experiments show that several recurrently differentially expressed genes can strongly regulate HCC cell invasions.

Comparative Transcriptome Analysis Reveals That the Extracellular Matrix Receptor Interaction Contributes to the Venous Metastases of Hepatocellular Carcinoma

Integrative molecular analysis of metastatic hepatocellular carcinoma

Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma

Transcriptome and Proteome of Human Hepatocellular Carcinoma Reveal Shared Metastatic Pathways with Significant Genes.

Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma

Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma

Recurrently deregulated lncRNAs associated with HCC tumorigenesis and metastasis revealed by genomic, epigenomic, and transcriptomic profiling in paired primary tumor and PVTT samples

A new and rare type of hepatocellular carcinoma: survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma

Proteomics Analysis of Distinct Portal Vein Tumor Thrombi in Hepatocellular Carcinoma Patients

RMP Promotes Venous Metastases of Hepatocellular Carcinoma Through Promoting IL-6 Transcription.

Differential Combinatorial Regulatory Network Analysis Related to Venous Metastasis of Hepatocellular Carcinoma

Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy

Rna-Seq Analyses Generate Comprehensive Transcriptomic Landscape And Reveal Complex Transcript Patterns In Hepatocellular Carcinoma

Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets

Single-cell transcriptomics reveals tumor microenvironment changes and prognostic gene signatures in hepatocellular carcinoma

Identification of Prognostic and Metastasis-Related Alternative Splicing Signatures in Hepatocellular Carcinoma.

A Comprehensive Genome‐wide Analysis of Long Noncoding RNA Expression Profile in Hepatocellular Carcinoma

Insight into Hepatocellular Carcinogenesis at Transcriptome Level by Comparing Gene Expression Profiles of Hepatocellular Carcinoma with Those of Corresponding Noncancerous Liver

Identification of Portal Vein Tumor Thrombus with an Independent Clonal Origin in Hepatocellular Carcinoma Via Multi-Omics Data Analysis

Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma

Discovery and Verification of Key Liver Cancer Genes and Alternative Splicing Events Based on Second-Generation Sequencing Data Analysis